Follow-up care of women with an abnormal cytology in a low-resource setting

Cancer Detection and Prevention

Volumn 27, Issue 6, 2003, Pages 466-471

  Gage, Julia C ^a   Ferreccio, Catterina ^b   Gonzales, Miguel ^c   Arroyo, Raul ^d   Huivín, Militza ^d   Robles, Sylvia C ^e  

^a HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c Proyecto TATI   (Peru)

^d Dir Reg de Salud de S Martin   (Peru)

^e PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

Cervical intraepithelial neoplasia prevention and control; Cervix neoplasms prevention and control; Developing countries; Mass screening; Peru; Vaginal smears

Indexed keywords

EID: 0344304412     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdp.2003.09.004     Document Type: Article

References (28)

1. Miller AB, Nazeer S, Fonn S, Brandup-Lukanow A, Rehman R, Cronje H, et al. Report on consensus conference on cervical cancer screening and management. Int J Cancer 2000;86:440-7.
2. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low-and middle-income developing countries. Bull World Health Organ 2001;79:954-62.
3. Santos C, Munoz N, Klug S, Almonte M, Guerrero I, Alvarez M, et al. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 2001;85:966-71.
4. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents, vol. VII. IARC Scientific Publications No. 143. Lyon, France: International Agency for Research on Cancer; 1997.
5. Ministerio de Salud, Oficina de Estadïstica e Informática, Organización Panamericana de Salud del Perú. Situación de Salud en el Perú - Indicadores Básicos. Lima, Perú: El Ministerio de Salud del Perú; 1999.
6. El Instituto Nacional de Estadística e Informática. Censos nacionales 1993, IX de población, IV de vivienda. Lima, Perú: El Instituto Nacional de Estadística e Informática; 1998.
7. SAS Institute Inc. SAS Version 6.12 of the SAS® System for Personal Computers; © 1996.
8. Pan American Health Organization. RedPac Laboratory Performance. Santiago, Chilé; 1999.
9. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Int Med 2000;132:810-9.
10. Lazcano-Ponce EC, Moss S, Alonso de Ruiz P, Salmeron Castro J, Hernandez Avila M. Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico. Arch Med Res 1999;30:240-550.
11. Cardin VA, Grimes RM, Jiang ZD, Pomeroy N, Harrell L, Cano P. Low-income minority women at risk for cervical cancer: a process to improve adherence to follow-up recommendations. Public Health Rep 2001;116:608-16.
12. Carey P, Gjerdingen DK. Follow-up of abnormal Papanicolaou smears among women of different races. J Fam Pract 1993;37:583-7.
13. Crane LA. Social support and adherence behavior among women with abnormal Pap smears. J Cancer Educ 1996;11:164-73.
14. Elwood JM, Cotton RE, Johnson J, Jones GM, Curnow J, Beaver MW. Are patients with abnormal cervical smears adequately managed? Br Med J, Clin Res Ed 1984;289:891-4
15. Fox P, Amsberger P, Zhang X. An examination of differential follow-up rates in cervical cancer screening. J Commun Health 1997;22:199-209.
16. Funke BL, Nicholson ME. Factors affecting patient compliance among women with abnormal Pap smears. Patient Educ Couns 1993;20:5-15.
17. Kavanagh AM, Simpson JM. Predicting nonattendance for colposcopy clinic follow-up after referral for an abnormal Pap smear. Aust N Z J Public Health 1996;20:266-71.
18. Lerman C, Hanjani P, Caputo C, Miller S, Delmoor E, Nolte S, et al. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol 1992;10: 330-3.
19. Marcus AC, Crane LA, Kaplan CP, Reading AE, Savage E, Gunning J, et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care 1992;30:216-30.
20. Massad LS, Anoina D. Colposcopic and cytologic findings among adolescents referred to two urban teaching hospitals. J Pediatr Adolesc Gynecol 1996;9:190-4.
21. Michielutte R, Dignan M, Bahnson J, Wells HB. The Forsyth County Cervical Cancer Prevention Project. II. Compliance with screening follow-up of abnormal cervical smears. Health Educ Res 1994;9:421-32.
22. Paskett ED, Phillips KC, Miller ME. Improving compliance among women with abnormal Papanicolaou smears. Obstet Gynecol 1995;86:353-9.
23. Schofield MJ, Sanson-Fisher R, Halpin S, Redman S. Notification and follow-up of Pap test results: current practice and women's preferences. Prev Med 1994;23:276-83.
24. Stewart DE, Buchegger PM, Lickrish GM, Sierra S. The effect of educational brochures on follow-up compliance in women with abnormal Papanicolaou smears. Obstet Gynecol 1994;83:583-5.
25. Thinkhamrop J, Lumbiganon P, Jitpakdeebodin S. Loss to follow-up of patients with abnormal Pap smear: magnitude and reasons. J Med Assoc Thai 1998;81:862-5.
26. Towler BP, Irwig LM, Shelley JM. The adequacy of management of women with CIN2 and CIN3 Pap smear abnormalities. Med J Aust 1993;159:523, 526-528.
27. Wagner E, Duggan MA. Effectiveness of follow up-letters to health care providers in triggering follow-up for women with abnormal results on Papanicolaou testing. CMAJ 2001;164:207-8.
28. Bishop A, Sherris J, Tsu VD, Kilbourne-Brook M. Cervical dysplasia treatment: key issues for developing countries. Bull Pan Am Health Organ 1996;30:378-86.